Literature DB >> 25179458

Tulip deformity with Cera atrial septal defect devices: a report of 3 cases.

Vikas Kohli1.   

Abstract

Device closure of secundum atrial septal defect (ASD) is the treatment of choice when anatomy is favourable. Amplatzer device has remained the gold standard for closure of ASD. Cobra deformity is a well-reported problem with devices. Recently, Tulip deformity has been reported in a single case. We report a series of cases where we noted Tulip deformity along with inability to retract the device in the sheath in Cera Lifetech devices. This resulted in prolongation of procedure, excessive fluoroscopic exposure and additional interventional procedures not usually anticipated in ASD device closure. We believe that the problem is due to the stiffness of the device resulting in its inability to be retracted into the sheath. We also report a unique way of retrieving the device.

Entities:  

Mesh:

Year:  2014        PMID: 25179458     DOI: 10.1007/s00246-014-1011-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  4 in total

1.  Cobrahead malformation of the Amplatzer septal occluder device: an avoidable compilation of percutaneous ASD closure.

Authors:  J C Cooke; J S Gelman; R W Harper
Journal:  Catheter Cardiovasc Interv       Date:  2001-01       Impact factor: 2.692

2.  "Cobra-like" deformation of an Amplatzer septal occluder.

Authors:  U Mazic; P Gavora; J Masura
Journal:  Pediatr Cardiol       Date:  2001 May-Jun       Impact factor: 1.655

3.  Tulip malformation of the left atrial disc in the Lifetech Cera ASD device: a novel complication of percutaneous ASD closure.

Authors:  Nicholas Hayes; Eric Rosenthal
Journal:  Catheter Cardiovasc Interv       Date:  2011-12-12       Impact factor: 2.692

4.  Fabrication of graded TiN coatings on nitinol occluders and effects on in vivo nickel release.

Authors:  Deyuan Zhang; Zhiwei Zhang; Zhenjun Zi; Yanhong Zhang; Weijun Zeng; Paul K Chu
Journal:  Biomed Mater Eng       Date:  2008       Impact factor: 1.300

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.